Galectin Therapeutics Investor Relations Material
Latest events
Study Result
Galectin Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Galectin Therapeutics Inc
Access all reports
Galectin Therapeutics Inc. is a biotechnology company that focuses on the development of therapies for fibrotic diseases, cancer, and other conditions related to galectin proteins. The company's research and development efforts are primarily centered on galectin-3, a protein that plays a critical role in various disease processes, including fibrosis and immune response. Galectin Therapeutics aims to create novel treatments that can potentially address unmet medical needs in these areas. The company is headquartered in Norcross, Georgia, and its shares are listed on the NASDAQ.
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
GALT
Country
🇺🇸 United States